Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'bcr/abl' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 912 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Druker, BJ
      Current treatment approaches for chronic myelogenous leukemia

      CANCER JOURNAL
    2. Rivas, C; Miller, ARM; Collado, M; Lam, EWF; Apperley, JF; Melo, JV
      BCR-ABL-expressing cells transduced with the HSV-tk gene die by apoptosis upon treatment with ganciclovir

      MOLECULAR THERAPY
    3. Bench, AJ; Cross, NCP; Huntly, BJP; Nacheva, EP; Green, AR
      Myeloproliferative disorders

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    4. Harrison, CJ
      Acute lymphoblastic leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    5. Campbell, JDM; Cook, G; Holyoake, TL
      Evolution of bone marrow transplantation - the original immunotherapy

      TRENDS IN IMMUNOLOGY
    6. Dietz, AB; Litzow, MR; Bulur, PA; Vuk-Pavlovic, S
      Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T(H)1 T cells

      CYTOTHERAPY
    7. Szer, J; Lieschke, GJ
      Small molecule: large hopes

      INTERNAL MEDICINE JOURNAL
    8. Maru, Y; Bergmann, E; Coin, F; Egly, JM; Shibuya, M
      TFIIH functions are altered by the P210BCR-ABL oncoprotein produced on thePhiladelphia chromosome

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    9. Krystal, GW
      Mechanisms of resistance to imatinib (ST1571) and prospects for combination with conventional, chemotherapeutic agents

      DRUG RESISTANCE UPDATES
    10. Weisberg, E; Griffin, JD
      Mechanisms of resistance imatinib (ST1571) in preclinical models and in leukemia patients

      DRUG RESISTANCE UPDATES
    11. Hood, KA; West, LM; Northcote, PT; Berridge, MV; Miller, JH
      Induction of apoptosis by the marine sponge (Mycale) metabolites, mycalamide A and pateamine

      APOPTOSIS
    12. Radojkovic, M; Ristic, S; Colovic, M; Todoric, B; Krtolica, K
      Busulfan-induced loss of Ph chromosome in chronic myeloid leukemia

      MEDICAL ONCOLOGY
    13. Heisterkamp, N; Voncken, JW; Senadheera, D; Hemmeryckx, B; Gonzalez-Gomez, I; Reichert, A; Pattengale, PK; Groffen, J
      The Bcr N-terminal oligomerization domain contributes to the full oncogenicity of P190 Bcr/Abl in transgenic mice

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    14. Benthin, M; Dallmann, I; Atzpodien, J
      13cis-and all-trans retinoic acid have antiproliferative effects on CML cells and render IFN alpha antiproliferative potency after combined treatmentin vitro

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    15. Bagg, A
      Minimal residual disease: How low do we go?

      MOLECULAR DIAGNOSIS
    16. Bartolo, C; Viswanatha, DS
      Molecular methods for minimal residual disease detection in hematolymphoiddiseases: Principles and applications

      JOURNAL OF CLINICAL LIGAND ASSAY
    17. Van Etten, RA
      Retroviral transduction models of Ph+ leukemia: Advantages and limitationsfor modeling human hematological malignancies in mice

      BLOOD CELLS MOLECULES AND DISEASES
    18. Honda, H; Hirai, H
      Model mice for BCR/ABL-positive leukemias

      BLOOD CELLS MOLECULES AND DISEASES
    19. Van Etten, RA
      Pathogenesis and treatment of Ph+ leukemia: recent insights from mouse models

      CURRENT OPINION IN HEMATOLOGY
    20. Wang, YL; Bagg, A; Pear, W; Nowell, PC; Hess, JL
      Chronic myelogenous leukemia: Laboratory diagnosis and monitoring

      GENES CHROMOSOMES & CANCER
    21. Chaplin, T; Jones, L; Debernardi, S; Hill, AS; Lillington, DM; Young, BD
      Molecular analysis of the genomic inversion and insertion of AF10 into MLLsuggests a single-step event

      GENES CHROMOSOMES & CANCER
    22. Shteper, P; Ben-Yehuda, D
      Molecular evolution of chronic myeloid leukaemia

      SEMINARS IN CANCER BIOLOGY
    23. Clark, RE; Christmas, SE
      BCR-ABL fusion peptides and cytotoxic T cells in chronic myeloid leukaemia

      LEUKEMIA & LYMPHOMA
    24. Kitzis, A; Brizard, F; Dascalescu, C; Chomel, JC; Guilhot, F; Brizard, A
      Persistence of transcriptionally silent BCR-ABL rearrangements in chronic myeloid leukemia patients in sustained complete cytogenetic remission

      LEUKEMIA & LYMPHOMA
    25. Vey, N; Balatzentko, G; LaFage, M; Sainty, D; Bouabdallah, R; Chabannon, C; Blaise, D; Gastaut, JA; Gabert, J
      Survey of early disapearance of BCR/ABL fusion transcript after allogeneicor autologous stem cell transplantation for chronic myelogenous leukemia

      LEUKEMIA & LYMPHOMA
    26. Perez-Losada, J; Gutierrez-Cianca, N; Sanchez-Garcia, I
      Philadelphia-positive B-Cell acute lymphoblastic leukemia is initiated in an uncommitted progenitor cell

      LEUKEMIA & LYMPHOMA
    27. Ahmed, M; Dusanter-Fourt, I; Dugray, A; Dubrez, L; Novault, S; Bonnet, ML; Gisselbrecht, S; Varet, B; Solary, E; Vainchenker, W; Turhan, AG
      BCR-ABL fails to inhibit apoptosis in U937 myelomonocytic cells expressinga carboxyl-terminal truncated Stat5

      LEUKEMIA & LYMPHOMA
    28. Shiratsuchi, M; Muta, K; Minami, R; Motomura, S; Suehiro, Y; Abe, Y; Shiokawa, S; Umemura, T; Fukui, T; Nishimura, J; Nawata, H
      Aberrant BCR-ABL transcript with intronic insertion in a patient with Philadelphia chromosome-positive chronic myeloid leukemia: Implications for disease progression

      LEUKEMIA & LYMPHOMA
    29. Mauro, MJ; Druker, BJ
      Chronic myelogenous leukemia

      CURRENT OPINION IN ONCOLOGY
    30. Verweij, J; Judson, I; van Oosterom, A
      STI571: a magic bullet?

      EUROPEAN JOURNAL OF CANCER
    31. Grimaudo, S; Raimondi, MV; Capone, F; Chimirri, A; Poretto, F; Monforte, AM; Simoni, D; Tolomeo, M
      Apoptotic effects of thiazolobenzimidazole derivatives on sensitive and multidrug resistant leukaemic cells

      EUROPEAN JOURNAL OF CANCER
    32. O'Dwyer, ME; Druker, BJ
      Chronic myelogenous leukaemia - new therapeutic principles

      JOURNAL OF INTERNAL MEDICINE
    33. Cuenco, GM; Ren, RB
      Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia

      ONCOGENE
    34. Dorey, K; Engen, JR; Kretzschmar, J; Wilm, M; Neubauer, G; Schindler, T; Superti-Furga, G
      Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase

      ONCOGENE
    35. Greenland, C; Touriol, C; Chevillard, G; Morris, SW; Bai, RY; Duyster, J; Delsol, G; Allouche, M
      Expression of the oncogenic NPM-ALK chimeric protein in human lymphoid T-cells inhibits drug-induced, but not Fas-induced apoptosis

      ONCOGENE
    36. Xie, SH; Wang, Y; Liu, JX; Sun, T; Wilson, MB; Smithgall, TE; Arlinghaus, RB
      Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation

      ONCOGENE
    37. Hoover, RR; Gerlach, MJ; Koh, EY; Daley, GQ
      Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells

      ONCOGENE
    38. Wong, S; Witte, ON
      Modeling Philadelphia chromosome positive leukemias

      ONCOGENE
    39. Tuveson, DA; Willis, NA; Jacks, T; Griffin, JD; Singer, S; Fletcher, CDM; Fletcher, JA; Demetri, GD
      STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

      ONCOGENE
    40. Jia, L; Patwari, Y; Srinivasula, SM; Newland, AC; Fernandes-Alnemri, T; Alnemri, ES; Kelsey, SM
      Bax translocation is crucial for the sensitivity of leukaemic cells to etoposide-induced apoptosis

      ONCOGENE
    41. Peters, DG; Klucher, KM; Perlingeiro, RCR; Dessain, SK; Koh, EY; Daley, GQ
      Autocrine and paracrine effects of an ES-cell derived, BCR/ABL-transformedhematopoietic cell line that induces leukemia in mice

      ONCOGENE
    42. Constantino, S; Santos, R; Lacronique, V; Bouchaert, I; Monni, R; Bernard, O; Gisselbrecht, S; Gouilleux, F
      Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway

      ONCOGENE
    43. Lin, F; Monaco, G; Sun, T; Liu, JX; Lin, H; Stephens, C; Belmont, J; Arlinghaus, RB
      BCR gene expression blocks Bcr-Abl induced pathogenicity in a mouse model

      ONCOGENE
    44. Perlingeiro, RCR; Kyba, M; Daley, GQ
      Clonal analysis of differentiating embryonic stem cells reveals a hematopoietic progenitor with primitive erythroid and adult lymphoid-myeloid potential

      DEVELOPMENT
    45. Wakayama, T; Maniwa, Y; Ago, H; Kakazu, N; Abe, T
      A variant form of myelodysplastic syndrome with Ph- minor-BCR/ABL transcript

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    46. Sattler, M; Griffin, JD
      Mechanisms of transformation by the BCR/ABL oncogene

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    47. Maru, Y
      Molecular biology of chronic myeloid leukemia

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    48. Radich, JP
      Philadelphia chromosome-positive acute lymphocytic leukemia

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    49. Lion, T
      Debate round table on RT-PCR controls: Concluding remarks and mini-review - Current recommendations for positive controls in RT-PCR assays

      LEUKEMIA
    50. Velders, MP; ter Horst, SAJ; Kast, WM
      Prospects for immunotherapy of acute lymphoblastic leukemia

      LEUKEMIA
    51. Porosnicu, M; Nimmanapalli, R; Nguyen, D; Worthington, E; Perkins, C; Bhalla, KN
      Co-treatment with As2O3 enhances selective cytotoxic effects of STI-571 against Bcr-Abl-positive acute leukemia cells

      LEUKEMIA
    52. Yu, Q; Brain, J; Laneuville, P; Osmond, DG
      Suppressed apoptosis of pre-B cells in bone marrow of pre-leukemic p190(bcr/abl) transgenic mice

      LEUKEMIA
    53. Kawaguchi, Y; Jinnai, I; Nagai, K; Yagasaki, F; Yakata, Y; Matsuo, T; Kuriyama, K; Tomonaga, M
      Effect of a selective Abl tyrosine kinase inhibitor, STI571, on in vitro growth of BCR-ABL-positive acute lymphoblastic leukemia cells

      LEUKEMIA
    54. Ferrero, D; Foli, C; Giaretta, F; Argentino, C; Rus, C; Pileri, A
      Growth advantage of chronic myeloid leukemia CFU-GM in vitro: survival to growth factor deprivation, possibly related to autocrine stimulation, is a more common feature than hypersensitivity to GM-CSF/IL3 and is efficiently counteracted by retinoids +/- alpha-interferon

      LEUKEMIA
    55. Yamaguchi, H; Inokuchi, K; Sakuma, Y; Dan, K
      Mutation of the p51/p63 gene is associated with blastic crisis in chronic myelogenous leukemia

      LEUKEMIA
    56. Miyamoto, N; Sugita, K; Goi, K; Inukai, T; Iijima, K; Tezuka, T; Kojika, S; Nakamura, M; Kagami, K; Nakazawa, S
      The JAK2 inhibitor AG490 predominantly abrogates the growth of human B-precursor leukemic cells with 11q23 translocation or Philadelphia chromosome

      LEUKEMIA
    57. Blagosklonny, MV; Fojo, T; Bhalla, KN; Kim, JS; Trepel, JB; Figg, WD; Rivera, Y; Neckers, LM
      The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressingleukemia cells to cytotoxic chemotherapy

      LEUKEMIA
    58. Dugray, A; Geay, JF; Foudi, A; Bonnet, ML; Vainchenker, W; Wendling, F; Louache, F; Turhan, AG
      Rapid generation of a tetracycline-inducible BCR-ABL defective retrovirus using a single autoregulatory retroviral cassette

      LEUKEMIA
    59. Kramer, A; Loffler, H; Bergmann, J; Hochhaus, A; Hehlmann, R
      Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia

      LEUKEMIA
    60. Yokota, MI; Hino, M; Tatsumi, N; Nishioka, T; Tsuda, I
      RNA extraction from ethanol-fixed leukocytes trapped on polyethylene terephthalate filter for RT-PCR analysis

      BIOTECHNIQUES
    61. Kurzrock, R; Bueso-Ramos, CE; Kantarjian, H; Freireich, E; Tucker, SL; Siciliano, M; Pilat, S; Talpaz, M
      BCR rearrangement-negative chronic myelogenous leukemia revisited

      JOURNAL OF CLINICAL ONCOLOGY
    62. Wu, JH; Suzuki, H; Zhou, YW; Liu, W; Yoshihara, M; Kato, M; Akhand, AA; Hayakawa, A; Takeuchi, K; Hossain, K; Kurosawa, M; Nakashima, I
      Cepharanthine activates caspases and induces apoptosis in Jurkat and K562 human leukemia cell lines

      JOURNAL OF CELLULAR BIOCHEMISTRY
    63. Amabile, M; Gannini, B; Testoni, N; Montefusco, V; Rosti, G; Zardini, C; Terragna, C; Buonamici, S; Ottaviani, E; Soverini, M; Fiacchini, M; Bassi, S; de Vivo, A; Trabacchi, E; Saglio, G; Pane, F; Baccarani, M; Tura, S; Martinelli, G
      Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia

      HAEMATOLOGICA
    64. Zanella, I; Rossi, G; Finazzi, D; Capucci, A; Albertini, A; Cariani, E
      Quantification of bcr/abl mRNA expression by a rapid real time reverse transcription-polymerase chain reaction assay in patients with chronic myeloidleukemia

      HAEMATOLOGICA
    65. Campanini, F; Santucci, MA; Pattacini, L; Brusa, G; Piccioli, M; Barbieri, E; Babini, L; Tura, S
      Competitive polymerase chain reaction as a method to detect the amplification of bcr-abl gene of chronic myeloid leukemia

      HAEMATOLOGICA
    66. Perego, RA; Nosari, AM; Cornacchini, G; Bianchi, C; Corizzato, M; Morra, E
      Delayed cytogenetic response with prolonged interferon-alpha treatment in chronic myeloid leukemia patients: quantification of BCR-ABL transcript by competitive reverse transcription-polymerase chain reaction

      HAEMATOLOGICA
    67. de Bree, F; Sorbera, LA; Fernandez, R; Castaner, J
      Imatinib Mesilate - Treatment of chronic myeloid leukemia Brc-Abl tyrosinekinase inhibitor

      DRUGS OF THE FUTURE
    68. Fan, EJ; Ying, H; Zhao, CH
      Human stem cell model to study signal transduction and molecular regulation mechanisms in CML

      CHINESE MEDICAL JOURNAL
    69. Griffin, JD
      Phosphatidyl inositol signaling by BCR/ABL: opportunities for drug development

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    70. Mauro, MJ; O'Dwyer, ME; Druker, BJ
      ST1571, a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia: validating the promise of molecularly targeted therapy

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    71. Levitzki, A
      Protein tyrosine kinase inhibitors as therapeutic agents

      BIOORGANIC CHEMISTRY OF BIOLOGICAL SIGNAL TRANSDUCTION
    72. He, L; Feng, HP; Raymond, A; Kreeger, M; Zeng, Y; Graner, M; Whitesell, L; Katsanis, E
      Dendritic-cell-peptide immunization provides immunoprotection against bcr-abl-positive leukemia in mice

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    73. Buchdunger, E; Matter, A; Druker, BJ
      Bcr-Abl inhibition as a modality of CML therapeutics

      BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
    74. Ergin, M; Denning, MF; Izban, KF; Amin, HM; Martinez, RL; Saeed, S; Alkan, S
      Inhibition of tyrosine kinase activity induces caspase-dependent apoptosisin anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein

      EXPERIMENTAL HEMATOLOGY
    75. Jahagirdar, BN; Miller, JS; Shet, A; Verfaillie, CM
      Novel therapies for chronic myelogenous leukemia

      EXPERIMENTAL HEMATOLOGY
    76. Jorgensen, HG; Holyoake, TL
      A comparison of normal and leukemic stem cell biology in chronic myeloid leukemia

      HEMATOLOGICAL ONCOLOGY
    77. Condorelli, F; Salomoni, P; Cotteret, S; Cesi, V; Srinivasula, SM; Alnemri, ES; Calabretta, B
      Caspase cleavage enhances the apoptosis-inducing effects of BAD

      MOLECULAR AND CELLULAR BIOLOGY
    78. Zhang, ZW; Subrahmanyam, R; Wong, R; Gross, AW; Ren, RB
      The NH2-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl

      MOLECULAR AND CELLULAR BIOLOGY
    79. Cheng, HY; Schiavone, AP; Smithgall, TE
      A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells

      MOLECULAR AND CELLULAR BIOLOGY
    80. Drummond, MW; Holyoake, TL
      Tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia: so far so good?

      BLOOD REVIEWS
    81. Harrison, CJ
      The detection and significance of chromosomal abnormalities in childhood acute lymphoblastic leukaemia

      BLOOD REVIEWS
    82. Wassmann, B; Klein, SA; Scheuring, U; Pfeifer, H; Martin, H; Gschaidmeier, H; Hoelzer, D; Ottmann, OG
      Hematologic and cytogenetic remission by STI571 (Glivec) in a patient relapsing with accelerated phase CML after second allogeneic stem cell transplantation

      BONE MARROW TRANSPLANTATION
    83. Jandula, BM; Nomdedeu, J; Marin, P; Vivancos, P
      Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia

      BONE MARROW TRANSPLANTATION
    84. Li, SG; Couvillon, AD; Brasher, BB; Van Etten, RA
      Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling

      EMBO JOURNAL
    85. Mahon, FX
      Chronic myelogenous leukemic and tyrosine kinase inhibitors.

      REVUE DE MEDECINE INTERNE
    86. Tanaka, K; Minamihisamatu, M; Yagi, S; Kyo, T; Dohy, H; Kamada, N
      Two step mechanism for formation of complex 9;22 chromosome translocation in chronic myelocytic leukemia detected by fluorescence in situ hybridization

      EXPERIMENTAL ONCOLOGY
    87. Traxler, P; Bold, G; Buchdunger, E; Caravatti, G; Furet, P; Manley, P; O'Reilly, T; Wood, J; Zimmermann, J
      Tyrosine kinase inhibitors: From rational design to clinical trials

      MEDICINAL RESEARCH REVIEWS
    88. Harrison-Findik, D; Misra, S; Jain, SK; Keeler, ML; Powell, KA; Malladi, CS; Varticovski, L; Robinson, PJ
      Dynamin inhibits phosphatidylinositol 3-kinase in hematopoietic cells

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
    89. Terre, C; Bastie, JN; Garcia, I; Suzan, F; Cayuela, JM; Therond, P; Castaigne, S
      BCR/ABL fusion gene detected on 9q34 by fluorescence in situ hybridizationin an acute leukemia with two BCR/ABL positive clones, one Ph-negative andone Ph-positive

      CANCER GENETICS AND CYTOGENETICS
    90. Gonzalez, FA; Anguita, E; Mora, A; Asenjo, S; Lopez, I; Polo, M; Villegas, A
      Deletion of BCR region 3 ' in chronic myelogenous leukemia

      CANCER GENETICS AND CYTOGENETICS
    91. Kin, Y; Shibuya, M; Maru, Y
      Inhibition of protein kinase C delta has negative effect on anchorage-independent growth of BCR-ABL-transformed Rat1 cells

      LEUKEMIA RESEARCH
    92. Holstein, SA; Hohl, RJ
      Interaction of cytosine arabinoside and lovastatin in human leukemia cells

      LEUKEMIA RESEARCH
    93. Kearney, PP; Boutros, R; Dodds, AJ; Biggs, JC
      Transformation to acute leukaemia in an MDS patient harbouring bcr-abl andbcl 2-IgH rearrangements, without expression of either activated oncogene

      LEUKEMIA RESEARCH
    94. Hagihara, M; Shimakura, Y; Tsuchiya, T; Ueda, Y; Gansuvd, B; Munkhbat, B; Chargui, J; Ando, K; Kato, S; Hotta, T
      The efficient generation of CD83 positive immunocompetent dendritic cells from CD14 positive acute myelomonocytic or monocytic leukemia cells in vitro

      LEUKEMIA RESEARCH
    95. Keil, F; Mitterbauer, G; Chen, X; Haas, OA; Kalhs, P; Lechner, K; Mannhalter, C; Moser, K; Worel, N; Pirc-Danoewinata, H; Louda, N; Loidolt, H; Rabitsch, W; Greinix, HT
      PBPC mobilization with chemotherapy and G-CSF in patients with chronic myeloid leukemia: quantification of bcr/abl-positive cells by interphase fluorescence in situ hybridization and competitive PCR

      TRANSFUSION
    96. Witte, O
      The role of Bcr-Abl in chronic myeloid leukemia and stem cell biology

      SEMINARS IN HEMATOLOGY
    97. Druker, B
      Signal transduction inhibition: Results from phase I clinical trials in chronic myeloid leukemia

      SEMINARS IN HEMATOLOGY
    98. Ruiz-Arguelles, GJ; Lopez-Martinez, B; Ramirez-Cabrera, JM; Reyes-Nunez, V; Rodriguez-Cedeno, HM; Garces-Eisele, J
      Molecular monitoring of the treatment of patients with BCR/ABL (+) chronicmyelogenous leukemia

      REVISTA DE INVESTIGACION CLINICA
    99. Druker, BJ; Talpaz, M; Resta, DJ; Peng, B; Buchdunger, E; Ford, JM; Lydon, NB; Kantarjian, H; Capdeville, R; Ohno-Jones, S; Sawyers, CL
      Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinasein chronic myeloid leukemia.

      NEW ENGLAND JOURNAL OF MEDICINE
    100. Mainville, CA; Parmar, K; Unnikrishnan, I; Gong, L; Raffel, GD; Rosenberg, N
      Temperature-sensitive transformation by an abelson virus mutant encoding an altered SH2 domain

      JOURNAL OF VIROLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 15:11:40